Journal Article (Review Article) DKFZ-2026-00968

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Digital twins in uro-oncology. [„Digital twins“ in der Uroonkologie].

 ;  ;  ;  ;  ;  ;

2026
Springer Medizin New York]

Die Urologie nn, nn () [10.1007/s00120-026-02827-2]
 GO

Abstract: Uro-oncology is moving toward precision medicine, driven by high-dimensional longitudinal data from imaging, pathology, molecular profiling, and follow-up. However, clinical decision-making often relies on static risk scores that cannot fully capture individual disease dynamics. Digital twins aim to integrate multimodal patient data and to provide patient-specific, dynamically updated simulation models, thereby enabling 'what-if' testing of interventions.How is a medical digital twin defined, which data foundation is available in uro-oncology, and which clinical use cases can be envisaged?This work comprises a narrative review including a description of the digital twin concept, a structured presentation of multimodal data (laboratory parameters, imaging, pathology, omics, long-term outcomes), and an overview of representative published applications (e.g., tumor growth reconstruction, virtual pathology, surgical 3D twins).Current digital twin research in uro-oncology largely represents partial digital twins (e.g., tumor progression models, virtual assessment, patient-specific 3D surgical planning). Potential clinical value of digital twins includes dynamic risk stratification, individualized treatment planning, and adaptive follow-up strategies. Major limitations relate to data quality, interoperability, external validation, interpretability, data privacy, and regulatory requirements for clinical deployment.Digital twins have the potential to enable a new era of predictive precision medicine in uro-oncology. Progress toward clinically actionable digital twins requires multimodal architectures, rigorous monitoring, and seamless integration into clinical workflows under robust governance and regulatory frameworks.

Keyword(s): Artificial intelligence ; Multimodal data integration ; Precision medicine ; Risk stratification ; Tumor growth

Classification:

Note: #LA:E250# / epub

Contributing Institute(s):
  1. NWG KKE Multiparametrische Methoden zur Früherkennung des Prostatakarzinoms (E250)
Research Program(s):
  1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2026
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Springer ; DEAL Springer ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-04-23, last modified 2026-04-24



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)